Aurora Cannabis (ACB)

Aurora’s portfolio includes a range of brands serving different consumer and patient segments. Names associated with the company include San Rafael ’71, Daily Special, Drift, Whistler, Being, and Greybeard. These brands cover categories such as dried flower, pre-rolls, oils, and other cannabis formats, depending on market rules and product availability. The company has historically placed particular emphasis on medical cannabis, where consistency, compliance, and patient support are important differentiators.

Although Canada remains a major source of revenue, Aurora also has an international footprint. The company has used medical cannabis export agreements and local market access strategies to reach jurisdictions outside Canada, including parts of Europe and Australia. These markets are typically more medical in nature and often require strict production and documentation standards, which makes regulatory capability an important part of Aurora’s competitive position.

Aurora operates in an industry known for rapid regulatory change, pricing pressure, and shifting consumer preferences. Its performance depends on factors such as production efficiency, brand demand, cost control, and the pace at which medical cannabis markets develop internationally. For investors, Aurora Cannabis is a listed cannabis operator with exposure to both Canada’s established market and selected overseas medical cannabis opportunities.